Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$1.98 - $2.74 $128,700 - $178,100
-65,000 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$0.8 - $2.85 $170,103 - $605,992
-212,629 Reduced 76.59%
65,000 $169,000
Q4 2020

Feb 08, 2021

BUY
$0.69 - $0.9 $72,539 - $94,616
105,129 Added 60.94%
277,629 $208,000
Q3 2020

Nov 09, 2020

BUY
$0.72 - $1.04 $124,200 - $179,400
172,500 New
172,500 $126,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $353M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.